Recent studies have shown that, besides blocking the cell cycle, CDK4/6 inhibitors also suppress tumor growth through multiple other mechanisms, including enhancing the cytostasis caused by signaling-pathway inhibitors, inducing senescence, regulating cell metabolism, and even promoting anti-tumor immune responses [18,21]. Here, CDK4 is linked to neoplasm.